How many employees does Stoke Therapeutics, Inc. have?

Stoke Therapeutics, Inc. reported 170 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 16, 2026. That is up 32.8% from a year earlier.

What is Stoke Therapeutics, Inc.'s revenue per employee?

Stoke Therapeutics, Inc. brought in $184M of revenue in fiscal Dec 2025, which is $1.08M per employee. That ranks 30 of 108 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Stoke Therapeutics, Inc. employees and revenue per employee

STOK · Biotechnology · $1.60B market cap

Stoke Therapeutics, Inc. had 170 employees at the end of fiscal Dec 2025, up 32.8% from a year earlier. Revenue for the year was $184M, up 404.5% from a year earlier, or $1.08M per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

170

+32.8% YoY

Revenue

$184M

+404.5% YoY

Revenue / employee

$1.08M

Peer median $459K

Rank in industry

30 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2022

Hover a year for the numbers.

STOK employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	170	$184M	$1.08M	+32.8%	+404.5%
Dec 2024	128	$36.6M	$286K	+16.4%	+316.3%
Dec 2023	110	$8.8M	$80K	-6.0%	-29.2%
Dec 2022	117	$12.4M	$106K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Stoke Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
IDYA IDEAYA Biosciences, Inc.	145	$219M	$1.51M	Efficient growth
MAZE Maze Therapeutics, Inc.	125	$168M	$1.34M	—
STOK Stoke Therapeutics, Inc.	170	$184M	$1.08M	Efficient growth
SNDX Syndax Pharmaceuticals, Inc.	298	$172M	$578K	Efficient growth
PHAT Phathom Pharmaceuticals, Inc.	371	$175M	$472K	Leaner
RGNX REGENXBIO Inc.	371	$170M	$459K	Efficient growth
RYTM Rhythm Pharmaceuticals, Inc.	414	$190M	$458K	Hiring ahead
MRVI Maravai LifeSciences Holdings, Inc.	435	$186M	$427K	Contracting
DNA Ginkgo Bioworks Holdings, Inc.	485	$170M	$351K	Contracting

Every Healthcare company

Questions about Stoke Therapeutics, Inc.

How many employees does Stoke Therapeutics, Inc. have?: Stoke Therapeutics, Inc. reported 170 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 16, 2026. That is up 32.8% from a year earlier.
What is Stoke Therapeutics, Inc.'s revenue per employee?: Stoke Therapeutics, Inc. brought in $184M of revenue in fiscal Dec 2025, which is $1.08M per employee. That ranks 30 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare STOK with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Stoke Therapeutics, Inc.'s annual reports (Form 10-K), latest filed March 16, 2026. This is data, not a recommendation to buy or sell STOK.